Authors
Loading...
Mendelian randomization reveals potential protective miRNAs against breast cancer, suggesting new biomarkers.
Ren et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: